| Eric Mason, MD | |
|
1120 E Elizabeth St # F01, Fort Collins, CO 80524-4044 | |
| (970) 498-2903 | |
| Not Available |
| Full Name | Eric Mason |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 8 Years |
| Location | 1120 E Elizabeth St # F01, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104270560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 57.027504 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Colorado Medical Center | Greeley, CO | Hospital |
| Banner Fort Collins Medical Center | Fort collins, CO | Hospital |
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alpine Ear Nose And Throat Pc | 9436127032 | 21 |
News Archive
Remote consulting practices should be adopted widely during the COVID-19 pandemic to help low and middle income countries to help combat the virus and to provide quality healthcare to patients in the long-term, argue a team of researchers at the University of Warwick.
Metabolic disorders such as obesity and diabetes appear to share risk factors with and may influence the development of Alzheimer's disease and other forms of dementia, according to several reports published in the March issue of Archives of Neurology.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
› Verified 7 days ago
| Entity Name | Alpine Ear Nose And Throat Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790720464 PECOS PAC ID: 9436127032 Enrollment ID: O20040921001320 |
News Archive
Remote consulting practices should be adopted widely during the COVID-19 pandemic to help low and middle income countries to help combat the virus and to provide quality healthcare to patients in the long-term, argue a team of researchers at the University of Warwick.
Metabolic disorders such as obesity and diabetes appear to share risk factors with and may influence the development of Alzheimer's disease and other forms of dementia, according to several reports published in the March issue of Archives of Neurology.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Mason, MD 915 Olentangy River Rd Ste 4000, Columbus, OH 43212-3154 Ph: (614) 293-9215 | Eric Mason, MD 1120 E Elizabeth St # F01, Fort Collins, CO 80524-4044 Ph: (970) 498-2903 |
News Archive
Remote consulting practices should be adopted widely during the COVID-19 pandemic to help low and middle income countries to help combat the virus and to provide quality healthcare to patients in the long-term, argue a team of researchers at the University of Warwick.
Metabolic disorders such as obesity and diabetes appear to share risk factors with and may influence the development of Alzheimer's disease and other forms of dementia, according to several reports published in the March issue of Archives of Neurology.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
› Verified 7 days ago
Dr. Mark Camden Loury, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2001 S Shields St Ste E101, Fort Collins, CO 80526 Phone: 970-493-5334 Fax: 970-493-3727 | |
Christopher Mark Eriksen, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1120 E Elizabeth St, F-101, Fort Collins, CO 80524 Phone: 970-221-1177 Fax: 970-416-1969 | |
Dr. Thomas Alexander Mcknight, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1120 E Elizabeth St Ste F101, Fort Collins, CO 80524 Phone: 970-498-2903 | |
Dr. Matthew Lee Robertson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1120 E Elizabeth St, #f-101, Fort Collins, CO 80524 Phone: 970-221-1177 | |
Bruce Michael Smith, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2121 E Harmony Rd, Suite 350, Fort Collins, CO 80528 Phone: 970-484-6373 Fax: 970-484-0382 | |
Dr. Stephen Michael Wold, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1120 E Elizabeth St Ste F101, Fort Collins, CO 80524 Phone: 970-221-1177 Fax: 970-484-5990 |